Palliative surgery in peritoneal carcinomatosis can make a difference of months in the survival of the patient with improved quality of life Published on 29/04/2021 PIPAC, a palliative technique for intraperitoneal administration of chemotherapy, can increase the average survival rate by between 16 and 42 months in patients with peritoneal carcinomatosis